Masters of Pathology Series – Hematopathology 2018 (CME Videos)

Masters of Pathology Series – Hematopathology 2018 (CME Videos)

OakStone CMEinfo

Hematopathology

Masters of Pathology Series

A comprehensive review of the updated WHO classification of hematopoietic neoplasms with special emphasis on new and changed criteria. Earn Lifelong Learning and SAM credits.

Expert Hematopathology Insight

In addition to detailed coverage of hematopoietic neoplasms, the Masters of Pathology Series — Hematopathology program covers selected topics in hemostasis, thrombosis, and red blood cell pathology commonly encountered in pathology practices. Designed for both the practicing pathologist and the pathologist in training, this CME course will help you to better:

• Use results of immunophenotypic, genetic, and molecular studies when diagnosing hematopoietic neoplasms
• Interpret the diagnostic tests used to evaluate hemoglobinopathy, thalassemia, and selected hemostasis disorders
• Understand practical aspects of new developments and updates as you prepare for exams or certification

Topics / Speakers:

• Acute Myeloid Leukemia – Sharad C. Mathur, MD

• Benign and Reactive Conditions of Lymph Nodes – Dennis P. O’Malley, MD

• Myeloproliferative Neoplasms – Sharad C. Mathur, MD

• Myelodysplastic Syndromes – Sharad C. Mathur, MD

• B-cell Neoplasms of Small Lymphocyte Size – Sharad C. Mathur, MD

• Aggressive B-cell Neoplasms – Dennis P. O’Malley, MD

• Hodgkin Lymphoma – Sharad C. Mathur, MD

• Immunosecretory Disorders – Sharad C. Mathur, MD

• Overview of T Cell Lymphomas – Dennis P. O’Malley, MD

• Lymphoblastic Leukemias, Lymphomas and Related Diseases – Dennis P. O’Malley, MD

• Overview of the Spleen – Dennis P. O’Malley, MD

• Hemoglobinopathies and Thalassemias – Sharad C. Mathur, MD

• Selected Topics in Hemostasis – Sharad C. Mathur, MD

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Date of Original Release: July 15, 2018

Estimated time to complete this activity: 11.5 hours

CME credit is awarded upon successful completion of a course evaluation and a post-test.

Learning Objectives

After viewing this program, the participant will be better able to:

• • Describe the current WHO diagnostic criteria for the diagnosis of hematopoietic neoplasms
  • Correctly utilize and interpret results of immunophenotypic, genetic, and molecular studies in the diagnosis and classification of hematopoietic neoplasms

• Summarize and correctly interpret diagnostic tests utilized in the evaluation of hemoglobinopathy, thalassemia, and selected disorders of hemostasis

Product Details